잠시만 기다려 주세요. 로딩중입니다.
KMID : 0359019910110020279
Korean Journal of Gastrointestinal Endoscopy
1991 Volume.11 No. 2 p.279 ~ p.283
The Efficacy of Benexate HCI Betadex in Treatment of Gastric Ulcer
양진모/Yang JM
채현석/이승헌/최명규/한석원/최상욱/정인식/정규원/선희식/Chae HS/Lee SH/Choi MG/Han SW/Choi SW/Chung IS/Chung KW/Sun HS/Kim BS
Abstract
Benexate HCl betadex (Ulgut) is a newly introduced antiulcer agent which stimulates production of mucus and enhanced mucosal blood flow on, gastric mucosa. This agent is known to have efficacy in treatment of peptic ulcer. This study was designed to evaluate the efficacy and safety of Benexate HCl betadex in treatment of gastric ulcer. Thirty-three patients with endoscopically diagnosed gastric ulcer were treated with Benexate HCl betadex 400 mg twice daily per os for 4 ar 8 week. Among them 3 patients were excluded due to missed during follow-up in two patients and one with gastric cancer, Every patients were assessed clinically and endoscopically before treatment, at 1 week, 2 weeks, 4 weeks, 6 weeks and 8 weeks after treatment. The result were as follows. 1) The rate of completely healing of gastric ulcer was 36.7% at 4 weeks and 76.7% at 8 weeks after the treatment. 2) Clinical symptoms(epigastric pain) disappeared in 96.7% of patients with gastric ulcer at 1 week. 3) Three patients developed side effects of drug including constipation, skin rash and liver function abnormality, respectively. These results demonstrated that Benexate HCl betadex 400 mg twice daily p.o. could be effective and safe in treatment of gastric ulcer patients.
KEYWORD
FullTexts / Linksout information
 
Listed journal information
학술진흥재단(KCI) KoreaMed 대한의학회 회원